Goodwin @ JPMorgan

We are looking forward to seeing you at the 38th Annual JP Morgan Healthcare Conference in San Francisco. Below please find details on Goodwin-sponsored events and attendees. We are looking forward to connecting with you!

Monday, January 13, 2020: Celebrate with Us: Annual Wine + Beer Tasting Reception at Press Club

Wednesday, January 15, 2020: Learn with Us: Goodwin + KPMG @ JPMorgan Symposium at the St. Regis Hotel

Attendees: A list of Goodwin Partners attending

Local Restaurants: Dine with Us: A list of recommended restaurants and reservations information

Monday, January 13, 2020

JP Morgan Reception 20 

Celebrate with Us: Annual Wine + Beer Tasting Event at Press Club

6:30 pm – 9:30 pm

Press Club
20 Yerba Buena Lane
San Francisco, CA 94103

Please contact us to register guests. Click here for directions.

Wednesday, January 15, 2020

JP Morgan Seminar 20

Learn with Us: Goodwin + KPMG @ JPMorgan Symposium at the St. Regis Hotel

  Goodwin hz logo              KPMG       


The St. Regis San Francisco
125 3rd Street
San Francisco, CA 94103

8:30 am – 8:45 am  Welcome Remarks

Burst 1: New Frontiers in Digital Diagnostics & Medtech

8:50 am – 9:05 am  Current State of the Healthcare Sector & Regulations

9:10 am – 9:55 am  New Frontiers in MedTech Space on the Global Stage: What are the Challenges in IP, Regulatory and Commercial

  • Kristin Ciriello Pothier, Global Healthcare and Life Sciences Strategy Leader, KPMG (Moderator)
  • Nicholas Mitrokostas, Partner, Goodwin
  • Stefan Scherer, Global Head of Experimental Medicine, GlaxoSmithKline (GSK)
  • Joseph Zaccaria, Client Growth Director, TrialSpark
  • Reena L. Pande, MD MSc, Chief Medical Officer, AbleTo

10:00 am – 10:45 am  Panel: Issues Facing Therapeutic Companies Using ML and AI in Drug Discovery Methods

  • Danielle Lauzon, Partner, Goodwin (Moderator)
  • David Berry, General Partner, Flagship; CEO, Integral
  • Dan Housman, Co-founder, CTO Graticule, Co-founder Courage Therapeutics

Keynote Speech

10:55 am – 11:40 am  Keynote Speaker - Stéphane Bancel, CEO, Moderna

11:40 am – 12:10 pm  Lunch Break

Burst 2: Europe Unleashed

12:10 pm – 12:40 pm  The Evolving Landscape for Growth-Stage Venture Funding in Europe

  • Sophie McGrath, Partner, Goodwin (Moderator)
  • Francesco De Rubertis, Co-Founder and Partner, Medicxi
  • Dirk Kersten, General Partner, Forbion

12:45 pm – 1:15 pm  Maximizing Returns through Structured M&As

  • Graham Defries, Partner, Goodwin (Moderator)
  • Erik van den Berg, CEO, AM-Pharma
  • Geert-Jan Mulder, Co-Founder and Managing Partner, Forbion
  • Maarten de Jong, Managing Director, Moelis & Company
  • Andy Stephenson, Partner, Advisory, Financial Due Diligence, KPMG

Burst 3: Knowing the Best IPO Strategy

1:20 pm – 1:40 pm  2020 Vision for the IPO Market

  • Amit Sinha, Managing Director, Investment Banking Division, Goldman Sachs

1:40 pm – 2:10 pm  Traditional US IPO Route: “The Two Minute Drill” to Complete a Successful IPO in the First Six Months of the Year

  • Janet Lehman, National Leader, VC Life Sciences, KPMG (Moderator)
  • Tom Koncsics, Partner, KPMG
  • Michael Bison, Partner, Goodwin
  • Jack Cassel, Vice President, Nasdaq
  • Amit Sinha, Managing Director, Investment Banking Division, Goldman Sachs

2:15 pm – 2:45 pm  Hong Kong IPO: Seizing Opportunities in a New Emerging Market for Biotech IPOs

  • Wendy Pan, Partner, Goodwin Hong Kong (Moderator)
  • Irene Chu, Partner, Head of New Economy and Life Sciences, Hong Kong, KPMG China
  • Michael Chan, Head of International Issuer Business, Hong Kong Exchanges and Clearing Limited (HKEX)
  • Bin Li, Founder and Chief Investment Officer, Lake Bleu Capital 

2:50 pm – 3:20 pm  Alternatives to U.S. IPO: Reverse Mergers and Direct Listings

  • Deepa Rich, Partner, Goodwin (Moderator)
  • Gerry Schemidt, Partner, Audit, KPMG
  • Mitchell H. Gold, Executive Chairman & CEO, Alpine Immune Sciences
  • David Snyder, Chief Financial Officer, Exicure

3:20 pm – 3:30 pm  Coffee & Networking

Burst 4: Trends in Biopharma

3:30 pm – 4:10 pm  Evaluating and Partnering New Technologies and Emerging Business Models

  • Kingsley Taft, Partner, Goodwin (Moderator)
  • Jeffrey Stoll, Principal, National Life Sciences Strategy Leader, KPMG
  • Nicholas Pullen, Ph.D., Executive Director of Inflammation & Immunology Integrative Sciences, Bristol-Myers Squibb

Burst 5: Mergers and Acquisitions

4:15 pm – 5:15 pm  The Brave New World of Antitrust in Life Sciences M&A

5:15 pm – 6:15 pm  Cocktails & Networking


Please click the button below to RSVP and register for the full day conference, Goodwin + KPMG @ JPMorgan Symposium, or register for individual Bursts.


Local Restaurants

GoodwinDines: Recommendations for restaurants in and around Union Square, Financial District and SOMA

Press Club - Click here to make a reservation.
20 Yerba Buena Lane

Delarosa - Seating is based on a first come, first served basis. 
37 Yerba Buena Lane

Kokkari - Click here to make a reservation.
200 Jackson St.

Slanted Door - Click here to make a reservation.
One Ferry Building, #3

Marlowe - Click here to make a reservation.
500 Brannan Street (On the corner at 4th)

Ozumo - Click here to make a reservation.
161 Steuart Street

Mourad - Click here to make a reservation.
140 New Montgomery Street

Wayfare Tavern - Click here to make a reservation.
558 Sacramento Street

Goodwin's Life Sciences Practice

Goodwin knows that succeeding in the life sciences industry is as much about strategy and execution as it is about research and development. In this highly competitive business, you need more than the best and brightest ideas - you need a legal and strategic partner that understands the challenges of securing funding, safeguarding intellectual property, establishing partnerships, bringing new products to market, opening up new revenue streams, and protecting existing products line.

Goodwin can help. We know the market, the players and the science. With a full service team of highly experienced lawyers resident in key life sciences hubs, Goodwin helps clients find the strategic paths that foster growth and minimize risk across all phases of the corporate life cycle.

Click here to learn more about Gooodwin's Life Sciences practice.

 Goodwin @ JP Morgan

Case Studies

Recent News

Big Molecule Watch

Big Molecule

Goodwin's Big Molecule Watch blog posts updates and analyses on regulatory issues, litigation, legislation, and other news in the ever-developing world of biosimilars. The editors of this blog have collectively been watching and engaging with the world of biosimilars (“big molecules”) since before the inception of the biosimilar industry in the U.S., and we’re excited to share the observations of our active watch on this new forum. Read the Big Molecule Watch Blog >>